SCOTT CREPEAU: Open Payments
NPI 1285367144 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,040 in 153 payments from 29 companies in 2025. Trend: 2023 $1,790 · 2024 $6,361 · 2025 $7,040
Speaker / faculty: $2,806Food & beverage: $2,749Travel & lodging: $970Consulting: $350Education: $165
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 14 | $4,315 |
| AstraZeneca Pharmaceuticals LP | 14 | $437 |
| Inspire Medical Systems, Inc. | 22 | $414 |
| Avadel CNS Pharmaceuticals, LLC | 18 | $380 |
| GlaxoSmithKline, LLC. | 14 | $207 |
| HARMONY BIOSCIENCES LLC | 14 | $156 |
| Viatris Specialty LLC | 12 | $151 |
| Axsome Therapeutics, Inc. | 5 | $103 |
| SANOFI-AVENTIS U.S. LLC | 1 | $98 |
| Grifols USA, LLC | 4 | $93 |
Products named: XYWAV, INSPIRE, LUMRYZ, DUPIXENT, WAKIX, AIRSUPRA, NUCALA, YUPELRI.
Industry payments across UT — which companies pay providers there.
